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Abstract
Neurocysticercosis (NCC), a helminth infection of the brain, is a major cause of seizures. The mediators responsible for
seizures in NCC are unknown, and their management remains controversial. Substance P (SP) is a neuropeptide produced
by neurons, endothelial cells and immunocytes. The current studies examined the hypothesis that SP mediates seizures in
NCC. We demonstrated by immunostaining that 5 of 5 brain biopsies from NCC patients contained substance P (SP)-positive
(+) cells adjacent to but not distant from degenerating worms; no SP+ cells were detected in uninfected brains. In a rodent
model of NCC, seizures were induced after intrahippocampal injection of SP alone or after injection of extracts of
cysticercosis granuloma obtained from infected wild type (WT), but not from infected SP precursor-deficient mice. Seizure
activity correlated with SP levels within WT granuloma extracts and was prevented by intrahippocampal pre-injection of SP
receptor antagonist. Furthermore, extracts of granulomas from WT mice caused seizures when injected into the
hippocampus of WT mice, but not when injected into SP receptor (NK1R) deficient mice. These findings indicate that SP
causes seizures in NCC, and, suggests that seizures in NCC in humans may be prevented and/or treated with SP-receptor
antagonists.
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Introduction
Neurocysticercosis (NCC) is a parasitic infection of the human
central nervous system that is caused by the pig tapeworm Taenia
solium. NCC is the major cause of acquired seizures worldwide and
now accounts for up to 10% of emergency room visits for seizures
in the southwestern United States [1–7].
Live T. solium cysts in the brain of NCC patients are surrounded
by little or no inflammation. Seizures are thought to result from
the granulomatous host response initiated by dead or dying cysts
rather than mediators produced by the parasite itself [5,8–11].
Since antihelmintic medications kill live cysts, a dilemma arises
regarding treatment with these agents.
The mediators responsible for inducing seizures in NCC are
not known; their identification may lead to more effective
strategies for prevention and/or treatment of seizures in this
disease. Substance P (SP) is a neuropeptide within the tachykinin
family produced by neurons, endothelial cells and immunocytes
such as lymphocytes and macrophages. Receptors for SP (NK1R)
are expressed by cells within and outside the central nervous
system including neurons, endothelial cells and immunocytes
[12–16]. SP signaling is involved in nociception [17] and
neuropathic inflammation. A few reports implicate SP in the
pathogenesis of seizures including one in which SP amplified
seizure responses in rats [18,19].
The studies reported herein were undertaken to examine the
hypothesis that SP is the epileptogenic agent in NCC. Our findings
in brain biopsies of patients with NCC and in rodent models of
NCC indicate that SP, produced within cysticercosis granulomas,
causes seizures and suggest that seizures in NCC patients can be
prevented and/or treated with SP receptor antagonists currently
available in the clinic.
Results
SP-positive (+) cells are demonstrated in the brains of
patients with NCC
To determine if SP-producing cells can be detected in the
brains of NCC patients with seizures, particularly within the
region of granulomatous inflammation surrounding the dead or
dying cyst, we performed immunohistochemistry on brain tissue
specimens from patients with and without NCC. Included were 5
patients with NCC who underwent craniotomy and brain biopsy
to remove intraparenchymal cysts and 2 individuals who died
from non-neurological causes (Figure 1). SP peptide expression
was readily detected within cells adjacent to parasite remnants in
each of the 5 NCC brain biopsy specimens; the level of
expression scored an average of 260.71. In contrast, no SP+
cells were found distant from the parasite in the NCC biopsy
specimens that included sufficient brain tissue; these distant areas
scored 0.560( p ,.05, Mann-Whitney test). Autopsy specimens
from patients without NCC displayed no SP+ staining cells
(score=0.560; p,0.05, Mann-Whitney test). These findings are
consistent with the hypothesis that SP is produced within the
granulomatous inflammation that surrounds dead or dying cysts
in NCC.
PLoS Pathogens | www.plospathogens.org 1 February 2012 | Volume 8 | Issue 2 | e1002489Injection of SP into the hippocampus of rats induces
seizures
To determine if SP alone is capable of inducing seizures, we
injectedSPdirectlyintothehippocampusofratsandexaminedthem
for seizure activity using direct observation and EEG monitoring
(Figure 2). Injection of SP (10 nanomoles) resulted in severe
behavioral seizures (Racine grade 4.560) and increased electrical
activity on EEG (1.0660.1 mV), which lasted 5.061.23 sec. In
contrast, injection of PBS elicited essentially no seizure activity
assessed by these parameters (p#0.001, Mann-Whitney test, all
comparisons). Thus, SP alone was epileptogenic in rats.
Epileptogenic activity within early stage cysticercal
granuloma extracts correlates with SP peptide levels and
is blocked by pre-treatment with SP receptor antagonist
(SRra)
We previously demonstrated in the T. crassiceps murine model of
cysticercosis that early and late stage granulomas form around the
Author Summary
Neurocysticercosis (NCC), is a helminth infection of the
brain that is caused by Taenia solium. NCC is the major
cause of acquired seizures worldwide. Live Taenia solium
parasites in the brain of NCC patients are surrounded by
little or no inflammation. Seizures are thought to result not
from parasitic infection per se, but from the chronic
granulomatous host response initiated by dying cysts.
Antiparasitic drugs can be used to kill the parasites, but
the symptoms may worsen due to the host inflammatory
responses being stimulated by the dying parasites. The
mediators that are responsible for mediating seizures in
NCC are not known; identification of the seizure media-
tor(s) may lead to prevention/treatment of seizures with
specific antagonists. In this important study, we demon-
strated that Substance P, a neuropeptide and pain
transmitter is responsible for seizures in NCC. These
studies have potential implications for treatment and
prevention of seizures in the setting of NCC.
Figure 1. SP immunostaining of brain tissue samples from NCC-infected and uninfected patients. Photomicrographs of brain biopsy
specimens of NCC-infected patients (P1 through P5) and brain autopsy specimens of NCC-uninfected patients (N1 and N2) are shown. Specimen
slides were stained with specific polyclonal rabbit anti-SP antibody (a-SP) or control rabbit serum. Fields shown are either adjacent to the parasite
(indicated by red arrow) or distant from parasite [when specimen size permitted (P1 and P2)], as indicated. SP+ cells are indicated by black arrows,
10006magnification. Data shown is representative of one independent experiment.
doi:10.1371/journal.ppat.1002489.g001
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[20,21]. Early stage granulomas contained parasite remnants and
produced Th1 cytokines and SP peptide, while late stage
granulomas did not contain parasite remnants or SP and produced
IL-4 in addition to Th1 cytokines [20,21]. Injection of extracts of
early, but not late stage granulomas into the hippocampus of rats
induces seizure activity [22]. Since the ability of early granuloma
extracts to induce seizures could not be attributed to the distinct
cytokine profiles within the two stages [23], we explored the
hypothesis that SP was responsible for seizures in this model of
NCC, by examining the ability of extracts of early vs. late
granulomas to induce seizures and determining whether or not a
correlation existed between seizure activity and SP peptide level
(Figure 3). Seizure activity in rats was induced in all cases following
intrahippocampal injection of extracts of early stage granulomas
(12 of 12). In contrast, seizure activity was induced in only 1 of 7
extracts of late granulomas (p,.005, Fishers exact test). In addition
to the frequency of seizure induction, the severity of seizure
activity was greater in rats receiving early vs. late granuloma
extracts as determined by behavioral seizure grade (3.1760 vs.
0.1460.13; p#0.001, Mann-Whitney test; Figure 3C), amplitude
of EEG electrical activity (1.4560 vs. 0.0760.1 mV; p#0.001,
Mann-Whitney test; Figure 3E) and total duration of seizure
activity (6.4361.11 sec vs. 0.7460.65 sec; p#0.01, Mann-Whit-
ney test; Figure 3G).
To determine the relationship, if any, between seizure activity
and levels of SP peptide within extracts, we measured SP peptide
in the extracts and correlated this with the intensity of seizure
responses. There was a significantly positive correlation between
SP levels and the behavioral seizure grade (R
2=0.789, p,0.001,
Pearson Correlation Coefficient; Figure 3D), the amplitude of
seizure activity (R
2=0.444, p,0.05, Pearson Correlation Coeffi-
cient; Figure 3F) and duration of seizure activity (R
2=0.537,
p#0.05, Pearson Correlation Coefficient; Figure 3H). These
findings add additional support to the hypothesis that SP
contributes to the ability of early granuloma extracts to cause
seizures.
Effect of SP receptor antagonist (SPra) pretreatment on
seizure responses induced by early granuloma extracts
SP binds to its cognate receptor, NK1R, to mediate its
effects. To support the contention that SP within early
granulomas mediated the seizures, we examined the effects of
pre-treatment with aprepitant, a SP receptor (NK1R) antago-
nist, on seizures induced by early stage granuloma extracts
(Figure 4). Injection of aprepitant (1 mg) 30 min before injection
of early stage granuloma extracts resulted in complete
abrogation of EEG seizure activity (p#0.001, Mann-Whitney
test, all comparisons).
Effect of SP receptor or NK1R deletion on seizure
responses induced by early granuloma extracts
To further support the above observation that SP was important
for induction of seizure activity, experiments were performed using
transgenic mice devoid of NK1R (NK1R
2/2). We thus examined
the effect of NK1R deletion on seizure activity induced by extracts
of early granulomas (Figure 5). Similar to the results in rats,
extracts of early granulomas obtained from wild type mice induced
seizures when injected into the hippocampus of mice generating
seizures with behavioral seizure grades of 2.560, electrical
amplitude of 1.5460.2 mV, and total duration of 4.6362.13 sec.
In contrast, no seizure activity was observed when extracts were
injected into NK1R
2/2 mice (p#0.05, Mann-Whitney test, all
comparisons).
Effect of SP deletion on seizure responses induced by
early granuloma extracts
To further establish that SP is the tachykinin within extracts of
early granulomas that binds to NK1R within the brains of rodents
to induce seizures, we examined whether early granulomas
obtained from SP precursor knockout (SPP
2/2) mice were
capable of inducing seizures when injected into the hippocampus
of wild type mice (Figure 5). Twelve granulomas from infected
SPP
2/2 mice were examined—7 early stage and 5 late stage.
Neither early nor late granuloma extracts from these mice induced
seizure activity.
Figure 2. Seizure activity in rats following intrahippocampal
injection of SP. A representative EEG recording before and after
injection of SP into the hippocampus of a rat is shown in panel A;
double black lines indicate period of SP injection. The behavioral seizure
grade (B), seizure amplitude (C), and seizure duration (D) following
intrahippocampal injection of SP or vehicle (PBS) in rats (n=4–6) are
depicted graphically (results shown are mean 6 SEM; *, p#0.001,
Mann-Whitney). Results are pooled data from two independent
experiments.
doi:10.1371/journal.ppat.1002489.g002
Substance P Causes Seizures
PLoS Pathogens | www.plospathogens.org 3 February 2012 | Volume 8 | Issue 2 | e1002489Substance P Causes Seizures
PLoS Pathogens | www.plospathogens.org 4 February 2012 | Volume 8 | Issue 2 | e1002489Discussion
We demonstrated that SP-producing cells are present in the
brain of NCC patients and are localized specifically to areas of
inflammation adjacent to the degenerating worms. Also, severe
seizures occurred in rats after intrahippocampal injection of SP
alone, as well as after injection of SP-containing extracts of
granulomas obtained from T. crassiceps-infected wild type (WT)
mice. In addition, seizure activity correlated with SP levels within
extracts and was prevented by intrahippocampal pre-injection of
aprepitant, a SP receptor antagonist. Furthermore, studies using
mice deficient in SP precursor or SP receptor (NK1R) demon-
strated that SP precursor was required to generate epileptogenic
granuloma extracts, and that the SP receptor (NK1R) was
required to respond to these extracts with seizure activity,
respectively. Taken together these findings strongly suggest that
SP produced within cysticercal granuloma causes seizures in
rodent models of NCC and together with the SP localization
findings in NCC patients suggest that seizures can be prevented
and/or treated in human NCC with SP receptor antagonists.
SP peptide is encoded by the preprotachykin A gene. The
protein product of this gene, preprotachykinin A, is cleaved to
form two active neuropeptides, SP and neurokinin A. The SP
precursor (preprotachykinin) knockout mice used in our studies are
deficient in both SP and neurokinin A. Consequently, our results
in SPP-knockout mice can be attributed to a deficiency in either
SP or neurokinin A. The possibility that neurokinin A, and not SP,
is mediatingseizuresinNCC is unlikely forseveralreasons. First,the
SP antibody used in the brain immunohistochemistry studies was
specific for SP and did not cross-react withneurokininA. Also,while
neurokinin A binds to NK1R, it binds with much lower affinity than
SP; while, the opposite is true for NK2R, NK2R binds neurokinin A
with much greater affinity than SP. Our results demonstrated a
complete absence of seizures in NK1R-knockout mice, which
express NK2R. If neurokinin A was the mediator of seizures in our
models of NCC, we would have anticipated persistent epileptogenic
activity within granuloma extracts in these mice.
The mouse model of cysticercosis due to Taenia crassiceps used in
these studies has previously been exploited by us and others as a
model to study the molecular pathogenesis of NCC [24–27].
Similar to T. solium infection in humans, live T. crassiceps cysts in
mice cause little or no inflammation, while dead or dying parasites
initiate a granulomatous reaction. The inflammatory response that
occurs around dead or dying T. crassiceps cysts can be separated
into early stage and late stage granulomas based on the extent of
destruction of the parasite, their cytokine profile, and their pattern
of SP peptide production [20,21]; early stage granulomas contain
parasite remnants, produce Th1 cytokines, and SP peptide while
late stage granulomas contain neither parasite remnants nor SP
and produce IL-4 in addition to Th1 cytokines [20,21]. Cytokines
such as TNF-a, IL-1b and IL-6 [28,29] have been shown to
induce seizures, However, in previous studies we were unable to
attribute the epileptogenicity of early granuloma extracts to their
distinct cytokine profile [20,23]. Our current findings provide
definitive support to the conclusion that it is not the repertoire of
cytokines present within early granuloma that induces seizures,
rather, the presence of SP peptide.
In addition to demonstrating that SP within cysticercal
granulomas causes seizures in a rodent model of NCC, this is
the first demonstration that SP alone causes seizures. SP previously
had been shown to evoke epileptiform responses in neurons [30].
Also, mice with disruption of the preprotachykinin A gene showed
a reduction in the duration and severity of seizures induced by
intrahippocampal administration of kainic acid or pentylenetetra-
zol [19]. In addition, Liu et al demonstrated that while
administration of SP (10 pmol) alone into the hippocampus of
rats had no effect, SP administration combined with stimulation of
the perforant path within the hippocampus resulted in severe self-
sustaining status epilepticus (SSSE) and generated a pattern of
acute hippocampal damage resembling that seen in status
epilepticus in patients [18]. Our findings establishing that SP
alone causes seizures raises the possibility that it contributes to
seizures seen in other infectious and/or inflammatory diseases
involving the brain.
These studies have potential implications for treatment and
prevention of seizures in the setting of NCC especially seizures
induced by antihelmintic treatment of NCC patients with viable
cysts. Current management options for patients with moderate
infections and viable cysts include antihelmintic treatment along
with administration of corticosteroids to reduce inflammation and
the predisposition to seizures initiated by dying parasites.
Antiepileptic drugs are used to treat NCC patients with
spontaneously-occurring seizures [31,32] and to prevent future
attacks; many patients must resign themselves to taking these drugs
for the rest of their lives [32]. However, both corticosteroids and
antiepileptic drugs can have severe side effects. Our finding that
SP causes seizures in NCC precipitated by the granulomatous
response to dead or dying cysts suggest the possibility of using SP
receptor antagonist for seizure prophylaxis during periods of
antihelmintic treatment and, perhaps, as an adjuvant or
replacement for anti-epileptic drugs for the treatment and/or
prevention of spontaneous seizures in NCC.
In addition to being induced by early granuloma surrounding
dead or dying cysts, seizures in NCC have been associated with
calcified lesions, which presumably represent end-stage granuloma
or scaring. Of note, calcified lesions with surrounding edema, in
particular, have been associated with episodic seizure activity [33–
35]. Based on our findings, it is tempting to speculate that SP
within the inflammatory response leading to edema around
calcified cysts causes seizures in this setting as well. However,
support for this hypothesis awaits further studies.
Materials and Methods
Brain immunohistochemistry
Human studies were approved the Institutional Review Board of
Baylor College of Medicine. Human subjects underwent neurosur-
gical procedures as part of their clinical standard of care and they
provided written informed consent to their treating physicians prior
to surgery. After diagnostic histopathology evaluation was done,
Figure 3. Seizure activity in rats following intrahippocampal injection of granuloma extracts. Representative EEG recordings after
injection of an early granuloma extract (A) or a late granuloma extract (B) into the hippocampus of rat are shown; double black lines indicate period
of extract injection. The behavioral seizure grade (C), seizure amplitude (E), and seizure duration (G) in rats following intrahippocampal injection of
early or late granuloma extracts (n=7–12) are depicted graphically (*, p#0.001, Mann-Whitney). Correlation between levels of SP peptide within the
granuloma extracts and behavioral seizure grade (D), seizure amplitude (F), and seizure duration (H) along with R
2 and p values are shown (blue
triangles represent each of the early stage granuloma extracts and pink triangles represent each of the late stage granuloma extracts). Results are
pooled data from three independent experiments.
doi:10.1371/journal.ppat.1002489.g003
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Human Institutional Review Board of Baylor College of Medicine
approval was obtained to use de-identified paraffin sections from
this archival material. Human brain tissue sections derived from 5
patients who were diagnosed with NCC associated seizures were
used to probe for SP peptide by immunohistochemistry. Human
brain tissue from 2 normal individuals who had died due to other
brain-related causes was used as control. Immunoperoxidase
staining was performed on 5 mm thick paraformaldehyde-fixed
human brain sections by using the avidin-biotin method, an
automated immunostainer (Biogenex), and polyclonal rabbit
antibody to SP (1:2500; Chemicon, Temecula, Calif.) or control
rabbit serum. Slides were scored on the basis of positive staining
demonstrated within the cytoplasm of cells at a level above the level
of the nonspecific signal in tissue cells. Five-to-ten high-power fields
(10006) of each slide were scored by an experienced microscopist
blindedto the study design. The slides were graded on a scale of 0 to
4+ as follows, 0–0.5+- no positive cells, faint diffuse staining; 1+,1 –
10% of cells positive, 2+, .10–20% of the cells positive; 3+, .20–
30% of the cells positive; and 4+, .30% of the cells positive.
Animal studies
All studies with animals were approved by the Institutional
Animal Care and Use Committee of Baylor College of Medicine.
Use of all animals involved in this project were carried out
according to the provisions of the Animal Welfare Act, PHS
Animal Welfare Policy, the principals of the NIH Guide for the
Care and Use of Laboratory Animals, and the policies and
procedures of Baylor College of Medicine. All surgery was
performed under DEA Schedule III anesthesia, and all efforts
were made to minimize suffering.
Mice
Six-week-old WT C57/BL6 mice were purchased from Jackson
Laboratories.Tachykinin1 orSPprecursorknockout mice (SPP
2/2)
mice were generated, as described [36]. Briefly, a targeting vector
containing neomycin resistance and thymidine kinase genes was
used to disrupt the Tac1 gene, replacing the SP exon 3 with neo
and deleting the neurokinin A exon 6. Chimeric animals were
backcrossed into the C57BL/6J for 15 generations. SPP
2/2 mice
are viable, fertile, normal in size and do not display any gross
physical or behavioral abnormalities. Nociceptive pain responses
and neurogenic inflammation are absent. SPP
2/2 male and
female mice were obtained from Dr. Julio Fontan, Southwestern
Medical Center, Dallas, Texas and bred within the BCM animal
facility. NK-1R
2/2 were generated as described [37]. Briefly, a
targeting vector was generated in which exon 1 of the NK-1R
gene was partially deleted, including the initiating methionine
codon, and replaced with a cassette encoding lacZ and neomycin
resistance. Chimeric animals were backcrossed into the C57BL/
6J for at least 15 generations. The homozygous NK1R
2/2 mice
expressed no detectable NK1 receptor peptide, were grossly
normal developmentally, were fertile, and appeared to be healthy
under barrier isolation conditions. NK1R
2/2 mice were
originally obtained from the laboratory of Dr. Joel Weinstock,
Tufts University School of Medicine, Boston, Massachusetts.
Rats
Adult Sprague Dawley rats (125–175 grams) were purchased
from Harlan Laboratories (Houston, Texas).
Murine cysticercosis model
Female wild type and SPP
2/2 mice (15–20 mice per group)
were infected by intraperitoneal inoculation with 10 cysts of the
ORF strain of T. crassiceps, as previously described [21,38]. All
infected animals were housed in a BSL2 facility at Baylor College
of Medicine. Three months following infection, the mice were
euthanatized by cervical dislocation under anesthesia. Granulomas
associated with parasites were identified visually, removed from
the peritoneal cavity, portioned into 3 parts and used for different
experiments as follows. One part of the granulomas was fixed in
4% paraformaldehyde to be utilized for histological staging, the
second part of the granuloma was frozen in liquid nitrogen to be
used for quantitation of SP peptide. The remainder was washed
once, followed by homogenization in phosphate buffered saline to
generate extracts for study of epileptogenic responses.
Granuloma staging
The portion of each granuloma fixed with 4% paraformalde-
hyde was paraffin-embedded and cut into 5-mm sections, which
were then stained with Giemsa and examined microscopically. We
separated the granulomas into early and late stages based on the
histological appearance of the degenerating parasite according to
previously described methods [20].
Extraction and quantitation of Substance P
Early and late stage granulomas were homogenized in 1%
trifluoroacetic acid (TFA) (1 ml/gram of tissue) and centrifuged at
17,000 g for 15 minutes at 2–8uC. A Sep-Pak C18 Cartridge
(Waters, Associates, Milford, MA) was prewetted with 100%
acetonitrile followed by 1% TFA in water. The supernatant was
then passed through the cartridge, followed by a wash with 10–
20 ml of 1% TFA. Protein was then eluted with 3 ml of a 60:40
solution of acetonitrile:1% TFA and dried using a centrifugal
concentrator under vacuum. The dried samples were then
reconstituted in assay buffer containing protease inhibitor,
aprotinin (500 KIU/ml, Sigma) and quantitated using ELISA kit
from R&D Biosystems. Results are expressed as picograms of SP
in 1 mg of total protein. Total protein was quantitated using the
Bradford method (cat no. 500-0006, Bio-Rad, Hercules, CA).
Generation of granuloma extracts for seizure
experiments
To prepare extracts for seizure experiments, each granuloma
was homogenized in phosphate buffer saline. The homogenate
was centrifuged at 10,000 rpm for 10 minutes and the supernatant
used for seizure experiments as underlined below. Total protein in
the supernatant was quantitated using the Bradford method (cat
no. 500-0006, Bio-Rad, Hercules, CA).
Rat and mouse seizure models
Examination of epileptogenic responses in rats. The rat
seizure model was performed, as previously described [22]. Briefly,
Figure 4. Effect of SP receptor antagonist (SPra) pre-treatment on granuloma extract-induced seizure activity in rats. Representative
EEG recordings in rats after intrahippocampal injection of an early granuloma extract pretreated without (A) or with SPra (B) are shown; double black
lines indicate the period of extract injection (A and B) or SP receptor antagonist injection (B only). The behavioral seizure grade (C), seizure amplitude
(D), and seizure duration (E) in rats following intrahippocampal injection of early granuloma extracts pre-treated without (Control) or with SPra (SPra;
n=6 each) are depicted graphically (*, p#0.001, Mann-Whitney). Results are pooled data from two independent experiments.
doi:10.1371/journal.ppat.1002489.g004
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acepromazine/xylazine (25/5/0.8 mg/kg) and placed in a
stereotaxic frame. A burr hole was drilled in the location above
the hippocampus area and a small tube and wire was lowered into
the hippocampus and cemented in place. A PE 10 tubing that was
attached to a 10 ml Hamilton syringe was attached to the small
tube in the brain. EEG activity of anesthetized rats and behavioral
seizures of conscious rats were observed after injection of 10
microliters of SP (10 nM) or granuloma extract supernatant
containing 25 mg of total protein into the brain. For recording of
EEG activity, a male electrical connector was soldered to the wire,
attached to an amplifier and then to a chart recorder. Results of
EEG recordings are expressed as seizure duration (duration time
in seconds) and seizure amplitude (D amplitude of seizure activity
calculated by subtracting baseline EEG amplitude from the
maximal seizure amplitude activity expressed in milli volts). For
observation of behavioral seizures, the animal was allowed to
recover fully from the anesthetic before injection of test sample.
Behavioral changes were observed and carefully described for up
to 6 hours after the injection. Behavioral seizures were scored
according to a previously defined scale of Racine et al [39]. Briefly,
this rating scale classifies mouth and face twitches and clonic head
movements as stages 1 and 2 respectively, the appearance of
contralateral forelimb clonus is designated as stage 3. The
progression to stage 4 is characterized by bilateral forelimb
clonus that is now associated with rearing. Stage 5 seizures involve
bilateral forelimb clonus with rearing and falling. Where indicated,
1 microgram of SP receptor antagonist (Emend, Merck,
Whitehouse, NJ) was injected 15–20 minutes prior to
intrahippocampal injection of test sample. Controls included
injection of rats with vehicle or SP receptor antagonist alone.
Examination of epileptogenic responses in mice. Briefly,
adult mice were anesthetized with ketamine/xylazine (80/16 mg/
kg) and placed in a stereotaxic frame. The mice were injected
intrahippocampally with granuloma extracts as mentioned above.
Three microlitres of the granuloma extracts containing 7–10 ug of
protein were used for intrahippocampal injection in anaesthetized
adult WT mice and anaesthetized NK1R
2/2 C57BL/6 mice. The
mice were then monitored for EEG seizure activity and behavioral
seizure activity as described above.
Identification of accuracy of injection site
Twenty-four hours after intrahippocampal injection, animals
were anesthetized with urethane (1.2 g/kg) and perfused through
the heart with 4% paraformaldehyde. The brain tissues were
equilibrated in 30% sucrose and 35 mm horizontal sections were
Nissl stained and examined for the needle track/injection site.
Statistical analyses
Statistical differences were determined using the Mann-Whitney
test, Student’s t-test or Pearson’s correlation test, as indicated.
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